N-(azide-PEG3)-N'-(m-PEG4)-Benzothiazole Cy5
N-(azide-PEG3)-N'-(m-PEG4)-Benzothiazole Cy5 Basic information
- Product Name:
- N-(azide-PEG3)-N'-(m-PEG4)-Benzothiazole Cy5
- Synonyms:
-
- N-(azide-PEG3)-N'-(m-PEG4)-Benzothiazole Cy5
- N-(azide-PEG4)-3,3-Dimethyl-3H-indole-N'-(m-PEG3)-Benzothiazole Cy5
- N-(azide-PEG3)-N'-(m-PEG4)-Benzothiazole Cy5
- CAS:
- 2107273-88-9
- MF:
- C39H54ClN5O7S
- MW:
- 772.4
- Mol File:
- 2107273-88-9.mol
N-(azide-PEG3)-N'-(m-PEG4)-Benzothiazole Cy5 Usage And Synthesis
Uses
N-(azide-PEG3)-N'-(m-PEG4)-Benzothiazole Cy5 is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. N-(azide-PEG3)-N'-(m-PEG4)-Benzothiazole Cy5 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Biological Activity
N-(azide-PEG3)-N'-(m-PEG4)-Benzothiazole Cy5 is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1].
IC 50
PEGs
References
[1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
N-(azide-PEG3)-N'-(m-PEG4)-Benzothiazole Cy5Supplier
- Tel
- 0431-80534353 19917294565
- et@chemextension.com
- Tel
- 0371-037163312495,13303845143 13303845143
- 3001379618@qq.com
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Tel
- 025-85563444 18351873721
- purchase@synzest.com
- Tel
- 010-60605840 15801484223;
- psaitong@jm-bio.com